"Apomorphine Sublingual Film Reduces Off Episodes In Parkinson's Disease"
Apomorphine sublingual film significantly reduces off episodes in patients with Parkinson's disease, according to results of a phase three study performed by researchers at the Icahn School of Medicine at Mount Sinai. "Although nearly a third of patients discontinued treatment primarily because of oropharyngeal side effects, apomorphine sublingual film provided an efficacious, on-demand treatment for off episodes for most patients with Parkinson's disease in this trial," said study author C. Warren Olanow, MD, professor emeritus of neurology and neuroscience and chair emeritus, department of neurology at the Icahn School of Medicine at Mount Sinai. He added, “The long-term safety and efficacy of apomorphine sublingual film are currently being investigated."
— C. Warren Olanow, MD, Professor Emeritus, Neurology, Neuroscience, Chair Emeritus, Department of Neurology, Icahn School of Medicine at Mount Sinai